Tukanic 150mg
Tucatinib
Tukanic 150mg is used in combination therapy for HER2-positive breast cancer. It blocks cancer cell growth and slows the progression of advanced or metastatic tumors.
- Strengths 150 mg
- Form Tablets
- Packaging Size 30 TAB
- Packaging Type Box
- Manufacturer ZISKA PHARMACEUTICAL
Description of Tukanic 150mg
Tukanic 150mg contains Tucatinib, a tyrosine kinase inhibitor used to treat advanced or metastatic HER2-positive breast cancer. It is typically prescribed in combination with other medications like trastuzumab and capecitabine. Tukanic 150mg works by targeting and blocking the HER2 receptor, which is responsible for the growth of cancer cells in certain breast cancers. This helps slow disease progression and may improve survival rates. It is taken orally and should be used under medical supervision. Regular monitoring of liver function and other health parameters is advised during treatment.
Ingredients of Tukanic 150mg
- Tucatinib
Usage of Tukanic 150mg
- Taken orally, twice daily
- Use in combination with other prescribed medications
- Follow your oncologist’s exact dosage instructions
Precautions for Tukanic 150mg
- Not recommended during pregnancy or breastfeeding
- Regular liver function monitoring is essential
- Inform your doctor of any other ongoing treatments
- Avoid alcohol and consult your doctor before taking new medications
More like this
Find related medicines from trusted suppliers. Explore similar products to ensure you get the right medication for your needs.
